AKER BIOMARINE Aker BioMarine is pleased to invite investors, analysts and media to its Capital Markets Update on Thursday 1 December at 09:00 (CET). The event will be webcasted at www.akerbiomarine.com. Program: 09:00 (CET): Presentations by executive management inAker BioMarine Approx. 10:20 (CET): Q&A conference call The accompanying presentation material for the Capital Markets Update will be published around 07:00 (CET) the same day. To participate in the Q&A conference call, please contact the conference call operator at the telephone numbers listed below. Please join the event prior to scheduled start time and provide the confirmation code or ask forAker BioMarine's Capital Markets Update. Phone numberNorway : +47 2350 2007 Phone number International: +44 (0) 330 336 9125 Confirmation code: 1155264 The presentations and Q&A conference call will be webcasted at www.akerbiomarine.com. For further information, please contact:Carl Christian Bachke , Investor Relations Mobile: +47 909 808 48 Email: carl.bachke@akerbiomarine.com AboutAker BioMarine ASA Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters ofAntarctica .Aker BioMarine is listed onOslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source
